Dr Reddy's reveals financial results for third quarter of 2010
Posted on 28/01/2010 in Pharmacy Supplier News
Dr Reddy's Laboratories has published its financial results for the third quarter of 2010 and revealed a year-on-year decline in consolidated revenues.
The company reported a figure of $373 million (231 million pounds) for the three-month period ending December 31st - a six per cent fall from the $397 million recorded one year earlier.
However, a consolidated revenues statistic of $1.2 billion for the first three quarters of the 2010 financial year was up on 2009 by nine per cent.
The success of Dr Reddy's global generics business was credited with the 14 per cent growth in revenues when the company published its financial results for the quarter ending September 30th 2009 last year.
It generated revenues of $807 million during the first nine months of the 2010 financial year ? an increase of approximately seven per cent on 2009.
